Preclinical and Clinical Investigation of Drugs I. Bronchodilators and Antiasthmatic Drugs

Herrmann G. Aynesworth M. B. : Successful treatment of persistent extreme dyspnea “Status Asthmaticus,” J. Lab. Clin. Med. 23: 135, 1937.

Beall G. N. : Decarboxylase inhibitors and histamine in guinea pigs, Biochem. Pharmacol. 14: 1907–1911, 1965.

Salem H. Jackson R. H. : Oral theophylline preparations; review of their clinical efficacy in the treatment of bronchial asthma, Ann. Allergy, In press.

Horton G. E. : The value and safety of nebulized aminophylline in acute bronchial asthma, J. Tenn. Med. Assoc. 59: 239–244, 1966.

Forster R. E. Dubois A. B. Briscoe W. A. Carlson E. Comroe J. H. Jr. : The lung: clinical physiology and pulmonary function tests, 2nd ed. Year Book Publishers, Chicago, 1962.

Salem H. Belej M. Aviado D. M. : Purinergic receptors in the lung, unpublished observations.

Afonso S. O'Brien G. S. : Inhibition of cardiovascular metabolic and hemodynamic effects of adenosine by aminophylline, Am. J. Physiol. 219: 1672–1674, 1970.

Sutherland E. W. Robison G. A. : The role of cyclic-3′,5′-AMP in responses to catecholamines and other hormones, Pharmacol. Rev. 18: 145–161, 1966.

Lichtenstein L. M. Margolis S. : Histamine release in vitro: inhibition by catecholamines and methylxanthines, Science 161: 902, 1968.

Orange R. P. Austen W. G. Austen K. F. : Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung, J. Exp. Med. 134: 1365–1485, 1971.

Szentivanyi A. : The beta adrenergic theory of the atopic abnormality in bronchial asthma, J. Allergy 42: 203–232, 1968.

Oskoui ML Aviado D. M. Bellet S. : Bronchopulmonary effects of caffeine in the anesthetized dog, Respiration 27: 63–73, 1970.

MacLaren W. R. : Elixophyllin® in the treatment of acute and chronic asthma: Clinical evaluation and pulmonary function studies, Ann. Allergy 17: 729–739, 1959.

Hofford J. M. : Bronchodilating aerosols: Comparative actions of a new method of administration, Del. Med. J. 35: 29–33, 1963.

Cho Y. W. Aviado D. M. Lish P. M. : Efficacy of a new bronchodilator, soterenol, on experimental locked-lung syndrome in dogs, J. Allergy 42: 36–48, 1968.

Aviado D. M. : Drugs for treatment of bronchial asthma. In: Krantz J. C. Jr. , ed., Pharmacologic principles of medical practice, 8th ed., The Williams & Wilkins Company, Baltimore, 1972.

Castillo J. C. De Beer E. J. : The tracheal chain. I. A preparation for the study of antispasmodics with particular reference to bronchodilator drugs, J. Pharmacol. Exp. Ther. 90: 104–109, 1947.

James G. W. L. : The use of the in vivo trachea preparation of guinea pig to assess drug action on the lung, J. Pharm. Pharmacol. 21: 379–386, 1969.

Salem H. Shemano I. Beiler J. M. Orzechowski R. Hitchens J. T. Clemente E. : Fenspiride – a non-sympathomimetic bronchodilator with anti-allergic activity, Arch. Int. Pharmacodyn. Ther. 193: 111–123, 1971.

Siegmund O. H. Granger H. R. Lands A. M. : The bronchodilator action of compounds structurally related to epinephrine, J. Pharmacol. Exp. Ther. 90: 254–259, 1947.

Herxheimer H. : Repeatable ‘microshocks’ of constant strength in guinea pig anaphylaxis, J. Physiol. 117: 251–255, 1952.

Church M. K. Collier H. O. J. James G. W. L. : The inhibition by dexamethasone and disodium cromoglycate of anaphylactic bronchoconstriction in the rat, Br. J. Pharmacol. 46: 56–65, 1972.

Rosenthale M. E. Dervinis A. : Improved apparatus for measurement of guinea pig lung-overflow, Arch. Int. Pharmacodyn. Ther. 172: 91–94, 1968.

Collier H. O. J. James G. W. L. : Humoral factors affecting pulmonary inflation during acute anaphylaxis in the guinea pig in vivo, Br. J. Pharmacol. 30: 283–301, 1967.

Klide A. M. Aviado D. M. : Mechanism for the reduction in pulmonary resistance induced by halothane, J. Pharmacol. Exp. Ther. 158: 28–35, 1967.

Nadel J. A. Salem H. Tamplin B. Tokiwa Y. : Mechanism of bronchoconstriction during inhalation of sulfur dioxide, J. Appl. Physiol. 20: 164–167, 1965.

Griffin J. P. Turner P. : Preliminary studies of a new bronchodilator (WG 253) in man, J. Clin. Pharmacol. 11: 280–287, 1971.

Knudson R. J. Constantine H. P. : An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects, J. Appl. Physiol. 22: 402–406, 1967.

Segal M. S. Beakey J. F. : Management of bronchial asthma, Ann. Allergy 5: 317–336, 1947.

Kennedy M. C. S. Thursby-Pelham D. C. : Some adrenergic drugs and atropine methonitrate given by inhalation for asthma: A comparative study, Br. Med. J. 1: 1018–1021, 1964.

Howard L. A. : The effect of oral theophylline on bronchospasm, J. Asthma Res. 8: 111–114, 1971.

Benjamin C. Van As A. : Clinical trial of intravenous hexoprenaline in asthma, S. Afr. Med. J. 46: 599–603, 1972.

Palmer K. N. V. Diament M. L. : Effect of aerosol isoprenaline on blood-gas tensions in severe bronchial asthma, Lancet 2: 1232–1233, 1967.

Ingram R. H. Jr. Krumpe P. E. Duffell G. M. Maniscalco B. : Ventilation-perfusion changes after aerosolized isoproterenol in asthma, Am. Rev. Respir. Dis. 101: 364–370, 1970.

Cohen B. M. : A comparison of the respiratory effects of SCH-13949W and isoproterenol aerosols in the treatment of patients with expiratory airflow disorders; preliminary analysis in a long-term trial in ambulatory patients, Postgrad. Med. J. 47(Suppl.): 63–71, March 1971.

Flora A. R. : Comparison of theophylline blood levels: Tablet vs. liquids, Curr. Ther. Res. 12: 611–617, 1970.

Blackwell E. W. Conolly M. E. Davies D. S. Dollery C. T. : The fate of isoprenaline administered by pressurized aerosols, Clin. Pharmacol. 39: 194–195, 1970.

Jackson R. H. Garrido R. Silverman H. I. Salem H. : Blood levels following oral administration of theophylline preparations, Ann. Allergy 31: 413–419, 1973.